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During differentiation,  alterations  in gene expression  result in the synthesis 
of cell-specific polypeptides. A specialized example occurs in the immune system 
where not only do ceils synthesize immunoglobulin (Ig), i but the fate of these 
molecules  presumably  changes  as  cells  differentiate.  In  the  resting  or  "Go" 
lymphocyte the  bulk  of the  Ig synthesized is  inserted  into  the  plasma mem- 
brane  (M-Ig),  where  it presumably  serves  as  a  receptor molecule for antigen 
recognition (1  3). After exposure to antigen, cells destined to become antibody 
formers undergo numerous divisions during which they presumably differentiate 
into plasma cells. In contrast to the product of the Go lymphocyte, the bulk of 
the  Ig synthesized  by  the  plasma  cell  is  secreted  into  the  extracellular  fluid 
(S-Ig) (4). This process of differentiation is "driven" by antigen and terminates 
when an amount of antibody sufficient to remove antigen is secreted  (5,  6). 
To approach control of this process we have studied a  clone of continuously 
growing  human  diploid  lymphocytes.  These  cells  appear  to  be  arrested  in 
differentiation somewhere between the G~ lymphocyte and the plasma cell, and 
both  secrete  Ig and  insert  it  as  a  presumed  receptor into  their  plasma mem- 
branes  (7).  A method developed to quantitate  the amount of Ig in the plasma 
membrane and cytoplasm (C-Ig) has been utilized to stud\" the amount and/or 
half  disappearance  time  of M-Ig,  C-Ig,  and  S-Ig in  logarithmically  growing 
and  synchronized cells.  After  treatment  of logarithmically growing cells  with 
* This  is publication  No.  521 from the Department of Experimental  Pathology,  Scripps 
Clinic and Research Foundation,  La Jolla, Calif. This research was supported by US Public 
Health  Service grants  AI-07007 and  CA-10596, US Atomic Energy Commission Contract 
AT (04-3)  -410, a grant from the Council for Tobacco Research, and  a grant from the Brown 
Hazen Fund from Research Corporation. 
~c Recipient of US Public Health Service Career Development Award AI-46372. 
1  Abbreviations used in  this paper: BSA-BB, borate-bovine  serum albumin  buffer;  C-Ig, 
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inhibitors of protein synthesis,  the half disappearance  time for detectable  M-Ig 
is  approximately  45  min.  By  contrast,  after  24  hr  of  treatment  of  logarith- 
mically  growing  cells  with  actinomycin  D,  synthesis  of  M-Ig  is  unaffected, 
whereas  total  cellular  nascent  p~lypeptide  synthesis  and  messenger  RNA 
(M-RNA)  synthesis  are reduced  by  approximately  95 %.  When  cells are  syn- 
chronized in G1 (stationary  phase)  without the use of metabolic inhibitors, the 
M-Ig is reduced by only about 25 %, whereas total  C-Ig is decreased  by 90 %  of 
that  in  logarithmically  growing  cells.  Some of  these  results  have  been  pre- 
sented  in preliminary  form  (7). 
Materials and Methods 
Reagents and Bu~ers.--The nonionic detergent nonidet P40  (NP-40)  was obtained from 
the Shell Chemical Company  (New York), cytosine arabinoside from the Upjohn Company 
(Kalamazoo, Mich.), actinomycin D from Mann Research Laboratories (New York), ethidium 
bromide from the Boots Pure Drug Co., Ltd.  (Poole,  England), puromycin from the Sigma 
Chemical Company  (St.  Louis,  Mo.),  and  cyclohexamide from  Calbiochem  (Los  Angeles, 
Calif.). Uridine-2-14C  (50 mCi/mM), uridine-5-3H (20 Ci/m~), L-leucine-4,5-3H (30 Ci/mM), 
and thymidine-2-14C  (50 mCi/m.~) were purchased from New England Nuclear Corp. (Boston, 
Mass.).  RSB buffer was  1.0  X  10  -~ ~  tris  (hydroxymethyI) aminomethane  (Tris)-HCl,  pH 
7.4, containing 1.0 )<  10  -2 ~t NaC1 and  1.5  >(  10-s ~  MgC12.  STE buffer was 5.0  )<  10  _2 M 
Tris-HC1,  pH  7.4,  containing  1.0  X  10  _2  ~t  ethylenediaminetetraacetate  (EDTA)  and 
1.0 X  10  -11~ NaC1. 
Maintenance of Cells.--Suspension cultures of the 8866 line of diploid human lymphocytes 
were maintained in Eagle's medium containing twice the usual concentration of vitamins and 
amino acids and  10% fetal calf serum on a gyratory shaker as previously described (8). Cul- 
tures seeded at a concentration of 2 )<  105 cells/ml reached a constant concentration of 3.0 X 
106 cells/ml in 5-6 days. Cellular exclusion of 0.05%  trypan blue was used as a  criterion of 
cell viability. 
Cloning of Cdls.--Clones  were obtained by the method of Coffino et al., except that diploid 
human fibroblasts (Wi38) were used as a feeder layer (9). 
Cell Cycle Analysis.--The various phases of the cell cycle were determined by measuring 
the rate of DNA synthesis and  number  of cells in mitosis. To determine the rate of DNA 
synthesis, 2-ml aliquots of medium containing cells were placed into prewarmed (37°C)  tubes 
containing 2/~Ci of thymicine-2-14C.  Mter 30 min, incorporation of radioactivity was stopped 
by addition of 5 vol of cold  (4°C)  Earle's saline. Cells were washed twice in Earle's saline, 
collected by centrifugafion at 800 g for 5 rain, and resuspended in 2 ml of cold 5% trichloro- 
acetic acid (TCA). The TCA-insoluble material was collected onto Millipore filters (Millipore 
Corp., Bedford, Mass.)  and radioactivity measured  (8). The number of cells in mitosis was 
ascertained using phase-contrast microscopy. 
Polysome Preparation  and  Determination of  Nascent Polypepticle Synthesls.--5  >(  107 
lymphocytes were  suspended  in  5.0 ml  of  prewarmed  (37°C)  Eagle's  medium  containing 
l~00th the normal amount of L-leucine  (~00th  medium). Mter 15 min, 10/~Ci of L-leucine- 
4,5-3H was added and incorporation allowed to proceed for 6 min followed by addition of 8 vol 
of cold (5°C)  Earle's saline.  After centrifugation cells were resuspended for 10 min at 4°C in 
1.0 ml of RSB containing 0.5% NP-40. Nuclei were removed by centrifugation at 2000 rpm 
at 4°C for 10 min, and the supernatant was made 0.25% with respect to sodium deoxycholate. 
The polyribosomes were sedimented in 7.5-45%  (w/w) sucrose  velocity gradients for 31//44 hr 
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at 4°C  (8). Fractions were collected through a  continuous recorder (0.5 cm light path) and 
radioactivity determined as previously described (8). 
isolation and Characterization of M-RNA .- 
Preparation  of M-RNA.--To  prepare  pulse-labeled M-RNA,  5.0  X  107  cells  were  re- 
suspended in 5.0 ml of warm  (37°C) media without serum and incubated for 20  rain  with 
either 10 pCi/ml of uridine-2-I4C  or 100 ~Ci/ml of uridine-5-~H.  The incorporation of radio- 
activity was terminated by addition of 8 vol of cold (4°C) Earle's saline, and polyribosomes 
were prepared as described above. The sucrose gradient fractions which contained the poly- 
ribosomes  (approximately the  bottom 40%  of  the  gradient)  were pooled,  made  1%  with 
sodium dodecyl sulfate (SDS),  2.0 X  10  -8 M EDTA, and 1.0 X  10  -I ~ in 2-mercaptoethanol. 
This method for obtaining and releasing pulse-labeled RNA from eukaryotic polyribosomes 
conforms to current criteria for M-RNA (10). After 30 rain at 22°C, NaC1 was added to a final 
concentration of 1.0  X  10  -1 M,  and  RNA was precipitated by addition of 2.5  vol of 95% 
ethanol at  -20°C.  If  carrier  nucleic  acid was  needed to  obtain complete precipitation of 
RNA, 100/Jg  of yeast transfer RNA (Mann Research Laboratories) was added. 
In some experiments, it was desirable to inhibit the synthesis of mitochondrial RNA and 
precursors to ribosomal RNA during pulse labeling.  Accordingly, ceils were incubated with 
ethidium bromide (1/~g/ml) and actinomycin D  (0.04 #g/ml) before addition of radioactivity. 
As has been reported for HeI,a cells  (11-14),  these doses of inhibitors completely suppressed 
respective incorporation of radioactivity into  mitochondriaI and  ribosomal  RNA  in  these 
lymphocytes but did not affect M-RNA synthesis.  2 
Velocity Sedimentation  of RNA.--RNA was resuspended in 0.5 ml of STE buffer and sepa- 
rated in 16 ml 15-30%  (w/w) linear sucrose gradients at 24,000 rpm for 17 hr in the SW 27 
(Spinco)  rotor.  Gradients were analyzed for absorbance at  260 nx using a  continuous-flow 
cell  and  a  Gilford  recording spectrophotometer (Gilford  Instrument  Co.,  Oberlin,  Ohio). 
Radioactivity was determined as previously described (8). 
Quantitation  of Cytoplasmic Ig  and  M-Ig.--Since  the present investigation depended on 
specific  determination of  the amount of  Ig polypeptides among an excess  of other cellular 
polypeptides, appropriate methods had  to be  developed. Some  of these methods have been 
published previously (15, 16), but for clarity certain points are emphasized here. 
I.  Antigens.--Purified IgG fragments such as  Fc, ~: or X chains were pooled myeloma pro- 
teins obtained from Dr. Hans Spiegelberg of our institution and iodinated with ~25I to achieve 
approximately 6.6  X  l0  -~ #Ci/3.1  X  10-9g of antigen protein (17). A working solution of 
the test antigen was prepared by dissolving the 12~'I trace-labeled IgG fragment to be tested 
in borate-bovine serum albumin (BSA-BB)  lmffer  (0.1 M borate, pH 8.3, containing 2 mg of 
BSA protein/ml of buffer)  to a final  labeled antigen concentration of 6.25 X  10  -9 g of antigen 
protein/ml. 
II.  Antibodies.  :l'he antibody preparation was hyperimmune rabbit anti-IgG.  However, 
antibody used does not have to be specific for IgG alone since  cross-reacting antibody  to 
albumin, Fc-g, etc. will not interfere with the quantitation of IgG fragments in this assay. All 
sera including antibody used in this system were decomplemented at 56°C for 30 min before 
use.  Dilutions of antibody were  made  in  deeomplemented normal  serum  diluted  1:10  in 
Spinner salts containing penicillin and streptomycin as a preservative. 
Since this system is based on the competition of cold unknown antigen with antigen-r-'~I for 
available antibody sites, it is necessary to carry out the assay in excess antigen-I25I (e.g., in 
excess antibody small  amounts of cold unknown antigen would  not be detectable). We have 
chosen as our base line that dilution of antibody which is capable of binding 50% of the IgG- 
1251 fragment added. The detailed procedure for construction of a standard curve is as follows: 
(a) The base-line  control  =  no inhibition. 50/~1 of 109~ heated normal serum (NS)  +  0.5 
or 1 ml aliquot of diluted anti-IgG. 
2 Lerner, R. A. Unlmblished observations. LERNER~  McCONAIIEY~  JANSEN,  AND  DIXON  139 
(b) Inhibitors =  whole IgG molecules or IgG fragments of known concentration. 50 gl of 
inhibitor (diluted in 2 mg of BSA-BB in 1 ml) known to contain protein in the range of 2- 
1500 X  10  -9 g plus aliquot of diluted anti-IgG milliliter are added. 
(c) "rubes are mixed and incubated at 4°C for 1 hr. 
(d)  Take duplicate or triplicate 100-~l samples from each inhibitor plus anti-IgG aliquot 
above and pipette into disposable 12- X  75-mm glass tubes. 
(e) Add 100/al of IgG-12~I fragment containing 3.1 or 6.25 X  l0  -9 g of protein. 
(f) As a  control for nonspecific precipitation of IgG-I2'~I fragment, add  100 ul of  10%  A 
NS -I- 100/,'l of IgG-125I fragment in duplicate or triplicate. (A =  heated) 
(g) As a control for reactivity of IgG-125I fragment with an excess of anti-IgG, add  100/al 
of anti-IgG diluted (1:100)  +  100/~l of IgG-125I  fragment in duplicate. 
(h) Mix and incubate at 4°C for 1 hr. 
(i)  Add  200#1  of  appropriate  (NH4)2SO4  concentration for  optimum  precipitation  of 
system under study. 3 
(j) Mix well and incubate at 4°C for 30 rain. 
(k) Centrifuge at 3000 rpm for 30 min. 
(1)  Decant supernatant and discard. 
(m) Resuspend precipitate in 1 ml wash (NH4)2SO4  which is at the same concentration as 
the final concentration after addition for the original precipitation. 
(n) Centrifuge at 3000 rpm and repeat step l. 
(o)  Dissolve precipitate in 100 ~l  of distilled water and count tubes in well-type gamma 
scintillation counter. 
(p) Calculations: 
(1) Per cent precipitated.- 
Per cent precipitated (corrected for nonspecific precipitation)  = 
experimental precipitate counts -- factor ;K experimental supernatant counts X  I00 
total counts added 
where factor  =  per cent precipitated nonspecifically X  (1 +  per cent precipitated non- 
counts in 10%/k NS only X  100 
specifically) where per cent precipitated nonspecifically = 
total counts added 
where experimental supernatant counts =  total counts added  -  experimental precipitate 
counts. 
(2) Per cent inhibition.- 
Per cent inhibition = 
per cent precipitated control (no inhibition) -- per cent precipitated experimental ;K  100. 
per cent precipitated control (no inhibition) 
(q) On semilogarithmic paper, plot per cent inhibition on the linear scale versus  total protein 
inhibitor added on the logarithmic scale. 
3 The  optimum  (NH4)2SO4  concentration  for  the  precipitation  of  IgG-12aI  fragments 
bound to antibody is dependent on the following factors:  (a) type of fragment from an indi- 
vidual IgG molecule (i.e. Fab/, Fc, etc.); (b) species from which the IgG fragment is derived 
(i.e. mouse, human, etc.) ; (c) species in which the hyperimmune anti-IgG is prepared. 
The following are optimum (NH~)2SO4  concentrations that have been determined in this 
laboratory: (a) rabbit anti-human IgG -1- human Fab'-125I, 40% (NH4)2SO4;  (b) rabbit anti- 
human IgG  ~-  human kappa  chain-125I, 40%  (NH4)2SO4;  (c)  rabbit anti-human IgG  -t- 
human lambda  chainJ25I,  44%  (NH4)2SO4,  (d)  rabbit anti-human IgG  +  Fc-125I,  40% 
(NH4) 2SO4; (e) rabbit anti-mouse IgG -~ mouse Fal)'-, kappa chain-, and Fc-125I, all =  47.5%. 140  PLASMA  MEMBRANE-ASSOCIATED  AND  SECRETORY  IG 
U) Quantitation ~( cell associated I~G.-- 
(a) A control inhibition curve is set up (as described above) with each set of cells. 
(b) Wash cell thoroughly (four times in large volume of sera-free media). 
(c) Resuspend cell pellet in 0.5-1 ml diluted anti-IgG in duplicate. 
(d)  Incubate 1 hr at 4°C,  resuspending cells gently every 15 min. Control studies are 
carried out to insure that in handling of cells detectable amounts of IgG fragments do not 
"leak" from these cells. 
(e) Centrifuge at 2000 rpm for 10 rain (700 g). 
(f) Decant absorbed anti-IgG and save; discard cell button. 
(g) Add 100-ol aliquots of absorbed anti-IgG from step e  to disposable  12-  X  75-ram 
glass tubes in duplicate or triplicate. 
(h)  The number of cells required to be on the linear portion of the control  inhibition 
curve varies from 1 X  106 (mouse peritoneal macrophages) to 2 X  I0  s (mouse thymocytes). 
The  quantitation of  human diploid  lymphocytes in  culture  can usually  be carried out 
with from 5 X  106 to 5 X  107 cells/test. 
In order to quantitate the inhibition achieved by unknown materials suspected of contain- 
ing IgG, it is necessary to determine the inhibition achieved by inhibitors (e.g.,  whole IgG 
molecules or fragments of  IgG).  We use whole IgG  molecules from normal serum pools as 
standard  inhibitors due  to  their relative constant antigenicity and  express  the  inhibition 
achieved by unknowns as equivalent to a  certain amount of a  standard IgG preparation. In 
this procedure  different pools of anti-IgG  may  give  somewhat different control inhibition 
curves but since the assay is based on comparative degrees of inhibition of known and un- 
known inhibitors, identical results are achieved with a variety of anti-IgG's as long as a single 
standard inhibitor is used throughout. Since different IgG-blocking preparations, even those 
made from serum pools,  will vary antigenically, their antigenic similarity to the labeled IgG 
fragment used will also vary. This variation is even greater when the blocking IgG's are de- 
rived from single myeloma sera. Therefore, the amount of IgG needed to achieve 50% inhibi- 
tion of any reaction will depend upon  the particular blocking preparation. Thus,  identical 
data cannot necessarily be generated using different standard inhibitors. 
Quantitation of as little as 1.0 X  10  -8 g of IgG fragments/1.0 X  l0 s cells is possible. Assay 
specificity and adaptability to cell surfaces and extracts were determined  by studying eight 
different cell lines with different phenotypes for M-Ig  (16).  Nonspecific binding of antibody 
to cultured lymphocytes, and thus, overestimation of the amount of Ig in various fractions did 
not occur. For example, lymphocyte lines which did not have Ig on the surface or in the cyto- 
plasm did not combine with antibody (16). 
To  ensure that M-Ig did  not simply represent secreted  Ig  molecules readsorbed to  the 
plasma  membrane, phenotypic mixing studies were  carried  out  (16).  WIL2 and 8866  ceils 
which had respective phenotypes for M-Ig of K -{- Fc-- and K -1- Fc4- were grown separately for 
2 days, harvested, and resuspended for 24 hr in media collected from the other cell llne (e.g., 
WIL2 cells into 8866 media). The phenotype and amount of M-Ig remained tile same for each 
cell line, thus adsorption of secreted molecules onto plasma membranes seemed unlikely. 
All the studies reported below were carried out in 8866  cells which synthesize IgG with 
K-type light chains. In this cell line there were approximately 1.0 X  l0 s molecules of K chain/ 
cell surface and 44 times this much in the cytoplasm of each cell (16). The t¢ chain:Fc fragment 
ratio on the surface was 2.6:1 and for the total cell was 3.9:1. 
RESULTS 
Half Disappearance  Time of M-Ig and C-Ig in Logarithmically  Growing Cells 
Treated with Inhibitors of Protein Synthesis.--To determine the half disappear- 
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treatment,  the  amount of n chain and Fc fragment present  on the membrane 
and in the cytoplasm determined (Fig. 1). 
The half disappearance times for membrane-bound ~ chains and Fc fragments 
were each approximately 45 min (Fig. 1). The equal rate of disappearance was 
reflected  in the  constant  K:Fc ratio  on the  membrane  throughout  the  study 
(insert,  Fig.  1).  The initial  half disappearance  time for cytoplasmic K chains 
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FIG. l.  The amount of M-Ig and C-Ig was determined  for a  culture  of logarithmically 
growing cells (0 time), and then puromycin was added to a final concentration  of 50 gg/ml. 
At intervals after addition of puromycin, M-Ig and C-Ig were determined. 
O -- O, K  chain cytoplasm; O- - ©, Fc-3' fragment cytoplasm;  • -- •, ~ chain membrane; 
• -  - •,  Fc-3' fragment  membrane;  (Insert) C)--©, cytoplasmic:membrane  K chain  ratio; 
~, ~ chain:Fc-~ fragment ratio in cytoplasm or membrane. 
and Fc frag~nents was approximately 2 and 1.5 hr, respectively. The faster rate 
of disappearance for M-Ig than C-Ig was illustrated by the approximate 2-fold 
increase in the cytoplasm:membrane K  chain ratio in the 1st hr after puromycin 
treatment  (insert, Fig. 1). In contrast to M-Ig K and Fc fragments, initial rates 
of disappearance of cytoplasmic K chains and Fc fragments differed from each 
other. This difference was shown by the increase in the K:Fc ratio during the 
1st  hour  after  treatment  with  puromycin  followed  by  a  gradual  return  to 
control ratios after 5 hr (insert, Fig. 1). To ensure that the rapid disappearance 
of M-Ig was not an artifact  caused by puromycin,  the  studies were repeated 142  PLASMA  MEMBRANI':-ASSOCL~TED  AND  SECRETORY  IG 
with  another  inhibitor  of protein  synthesis,  cyclohexamide  (50  ~,g/ml),  and 
similar  results  were  obtained. 
The fate of the C-Ig after treatment of cells with puromycin was determined 
by simultaneously measuring its accumulation in the media and disappearance 
from the  cytoplasm. As can be  seen  (Fig.  2)  there  was  almost  quantitative 
recovery from the media of ig lost from the cytoplasm after treatment of cells 
with puromycin. The fate of M-Ig cannot be established  in a  similar fashion, 
since it represents only approximately 2 % of the total cellular Ig in 8866 cells. 
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F~6.2. Logarithmically growing cells were washed three times in Earie's salts and sus- 
pended in fresh prewarmed (37°C) media which contained puromycin (50/~g/ml) and  the 
amount of Ig lost from the membrane or cytoplasm  and that which appeared in the media de- 
termined at intervals. 
O--O, C-Ig; O--e, M-Ig; A--A, Ig in the media. 
To evaluate what per cent of Ig which appeared in the culture media could 
come from M-Ig turnover, cells  were incubated in media without serum for 4 
hr and the total Ig which accumulated in the media measured. 2.25  X  10  -7 g 
of IgG equivalents appeared in the media in 4 hr for each  1.0  X  106 cells in 
culture; 1.0 X  l06 cells had a total of 2.6 X  10  -s g of IgG equivalents on their 
surfaces.  Using a half disappearance time for M-Ig of 45 min,  approximately 
6.9  X  10  -s g could appear in the media/1.0  X  10  ~ cells in 4 hr, which would 
account  for  only approximately  3%  of the  total. 
Amou~l  and  Half Disappearance Time of M-Ig and C-Ig in G1 Cells.--It 
was of interest  to  determine  if the  amount  and  half disappearance  time  for 
M-Ig differered  in  growing  and  stationary  phase  cells.  We  have  previously LERNER,  McCONAHEY,  JANSEN~  AND  DIXON  143 
shown  that  stationary phase  diploid  lymphocytes were  arrested  in  the  G, 
phase of the cell cycle and did not secrete Ig (8). In the present experiment,  5 
day  s after seeding (2.0 X  10a/ml), cells reached a maximum density of approxi- 
mately 3.0  X  106 cells/ml, and by 8 days the rate of DNA synthesis in the 
culture was only 2 % of maximum in logarithmically growing cells. When cells 
were  obtained from this  stationary phase  culture  and  resuspended in  fresh 
media, there was an 8 hr lag followed by a wave of DNA synthesis and then 
mitosis, showing that in these experiments stationary phase lymphocytes were 
arrested in the Gz phase of the cell  cycle. The amount of M-Ig and C-Ig in 
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FIC. 3.  The  amount of  M-Ig  and C-Ig was determined  for  a  culture  of  logarithmically 
growing cells (0 time), and then actinomycin D was added to a final concentration of 5/ag/ml. 
At intervals cell viability and the amount of M-Ig and C-Ig were determined. 
O- -O, ~ chain membrane; O--O, Fc-3' fragment membrane; A~k,  ~ chain cytoplasm; 
&--&, Fc-y fragment cytoplasm. 
stationary phase cells was approximately 70 and 10%, respectively, of that in 
logarithmically growing cells, and the half disappearance of M-Ig after treat- 
ment of cells with puromycin was again 45 min. 
Half Disappearance Time of M-Ig in Logarithmically Growing Cells Treated 
with Actinomycin D.--To determine the half disappearance time of M-Ig after 
treatment of cells with an inhibitor of transcription of RNA, logarithmically 
growing cells were treated with actinomycin D  (5 ~g/ml) and membrane and 
cytoplasmic K  chains and Fc fragments measured at intervals after drug treat- 
ment. Within the 1st hour, membrane and cytoplasmic K chains and Fc frag- 
ments increased  above  control  values  (Fig.  3).  This  is  consistent with  our 
previous report that an early effect of actinomycin D  in cultured lymphocytes 
was to increase the rate of total Ig synthesis (8).  During the next 7 hr,  the 144  PLASMA MEMBRANE-ASSOCIATED AND  SECRETORY Io 
amount of K chain and Fc fragment in the membrane decreased  only approxi- 
mately 20% of the maximum level and then declined more slowly for the next 
40  hr  (Fig.  3). 
In contrast to M-Ig, C-Ig declined little during the first 4 hr, rapidly in the 
next 4 hr to about 50G. of control, then the rate changed and they decreased by 
C.D=.33 
1111=.10 / 
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FIG. 4.  Polyribosomes were prepared  from 5.0  ;<  I07 logarithmically  growing cells and 
sedimented  through  7.5-45%  w/w linear  sucrose gradients  as  described in  Materials  and 
Methods  (0 hr). Actinomycin D  (5/ag/ml)  was added, and at intervals after addition of the 
inhibitor, polyribosomes were prepared. The absolute OD 260 and time after addition of actino- 
mycin D for each profile are indicated by arrows. 
only an additional 20% over the next 42 hr (Fig. 3). During this time >95 % of 
the  cells  remained  viable. 
Since one possible  explanation  for the  above results  was  that  the  M-RNA 
which coded for M-Ig was long-lived, it was of interest  to study the haiLlife of 
total  cellular  M-RNA  in  cultures  of  our  lymphocytes.  Accordingly,  poly- 
ribosome profiles  and  total  nascent  polypeptide  synthesis  were  studied  after 
treatment  of cells  with  actinomycin  D  (5  #g/ml).  By  24 hr,  the  OD260  of 
polyribosomes had decreased to approximately 15 %  of control and the amount 
of 74S monosomes increased over &fold (Fig.  4).  The monosome to polysome LERNER~ McCONAIIEY, JANSEN~ AND  DIXON  145 
ratio  increased  from approximately 1:26  in  cells  24 hr  after treatment with 
actinomycin  D.  During  the  first  15  hr  after  treatment,  the  polyribosome 
profile shifted from monophasic to biphasic  (Fig.  4).  A  similar shift in poly- 
ribosome profile is seen when logarithmically growing cells are synchronized in 
G1 (8). The amount of nascent polypeptide synthesis decreased with an average 
half time of 4 hr to 4% of control in 24 hr  (Fig.  5).  If the  differences in the 
disappearance  of  M-Ig and  C-Ig are  due  to  cessation  of  synthesis  of  their 
respective  M-RNA's,  these  results  would  suggest  that  in  lymphocytes,  the 
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FIG. 5. To determine each point on the curve, a culture of logarithmically growing cells  was 
divided into two. One received actinomycin D (5 gg/ml) for the interval indicated, and the 
other was untreated. Each culture was pulse labeled with leucine-4,5-~H, polyribosomes  pre- 
pared and sedimented through 7.5-45% sucrose gradients, and fractions collected as described 
in Materials and Methods. Radioactivity associated with the polyribosomes (approximately 
bottom 40% of the gradient) was determined and expressed as a percentage of nascent peptide 
synthesis of the untreated culture. 
M-RNA which  codes for M-Ig is more long-lived than 96 %  of other cellular 
M-RNA's. 
Since actinomycin D  affects protein synthesis only secondarily via cessation 
of M-RNA formation, it was important for our studies to measure directly its 
effects on total cellular M-RNA synthesis in the lymphocytes studied. Cells were 
pulse labeled for 20 min with uridine-2-14C  and studied  either immediately or 
24 hr after addition of actinomycin D  (5/~g/ml). The disperse profile of sedi- 
mentation of pulse-labeled polyribosome associated RNA after a 20 min pulse, 
typical of that described for eukaryotic M-RNA,  was obtained  (10).  Clearly 
very  little  information  about  the  disappearance  of  rapidly  labeled  M-RNA 146  PLASMA  MEMBRANE-ASSOCIATED  AND  SECRETORY  IG 
after  treatment  with  actinomycin D  could be obtained in  this  way,  since the 
precursors  to ribosomal  RNA  were  also  labeled  in  a  20 min  pulse  and  then 
"chased" in the next 24 hr into 18S and 28S ribosomal RNA which completely 
obscured  quantitative  determination  of  any  remaining  M-RNA.  Therefore, 
advantage  was  taken  of the  fact  that  in  cells  pretreated  with  low  doses  of 
actinomvcin D  (0.04 #g/ml)  and ethidium bromide (1 #g/ml),  transcription of 
ribosomal precursor RNA and mitochondrial  RNA are completely suppressed 
lal  IbJ 
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I~'IG. 6.  1.0 X  10 s cells from the logarithmic phase of growth were incubated for 2 hr with 
actinomycin D (0.04/ag/ml) and ethidium bromide (1 ~g/ml). Cells were harvested, pulse la- 
beled for 20 rain with uridine-2-14C, and polyribosomes and M-RNA prepared immediately 
from half the culture as described in Materials and Methods. The remaining cells were resus- 
pended in complete media containing actinomycin D (5/ag/ml) and allowed to incubate for 24 
hr, and polyribosomes and M-RNA prepared.  The M-RNA was sedimented through  16 ml 
linear 15-30C}, (w/w) sucrose gradients and fractions collected as described in Materials  and 
Methods. 
Panel  (a), 20 rain pulse-labeled M-RNA.  --, OD 260 (ribosomal RNA); O--O, cpm X 
10  -2" 
Panel  (b), 20 rain pulse-labeled M-RNA followed by 24 hr  chase  in  actinomycin  D  (5 
/.lg/ml). O--O, cpm X 10  -2. 
during a short pulse label. Therefore, after subsequent addition of large amounts 
of  actinomvcin  D  (5  #g/ml),  one  is  presumably  observing  simply  M-RNA 
decay uncomplicated  by processing of other  cytoplasmic RNA's.  The results 
of such an experiment are illustrated  in Fig. 6, panel a  and b. Pretreatment  of 
cells with low doses of actinomycin D  did not suppress the synthesis of M-RNA 
but  completely  obliterated  incorporation  of  radioactivity  into  ribosomal 
RNA even after long chase periods.  The total  radioactivity incorporated into 
M-RNA with or without pretreatment  with low doses of actinomycin D  (0.04 
#g//ml) was almost identical.  After 24 hr of treatment with 5 #g/ml of actino- 
mvcin D,  only 7 %  of the  radioactivity incorporated into M-RNA remained. LERNER~ McCONAI-IEY~ JANSEN, AND  DIXON  147 
This is in good agreement with the results presented above for nascent poly- 
peptide synthesis. 
DISCUSSION 
In the present investigation some features of the control of C-Ig and M-Ig 
have been presented. It seems clear that detectable M-Ig has a half disappear- 
ance time of approximately 45 rain after inhibition of protein synthesis with 
puromycin  and  cyclohexamide.  Since  M-Ig  disappears  rapidly  even  in  the 
absence of protein synthesis, it is unlikely that actinomycin D  causes M-Ig to 
persist by terminating the synthesis of a short-lived polypeptide necessary for 
catabolism of M-Ig. Of course, any of the inhibitors used might affect receptors 
which bind M-Ig rather than synthesis of M-Ig or alter stearic arrangement of 
M-Ig  on cell surface either of which might  cause its nondetection. The fact 
that  M-Ig persists longer after treatment with actinomycin D  than approxi- 
mately  90%  of  total  cellular  nascent  polypeptides  may  offer technical  ad- 
vantages for its isolation. 
The fates of M-Ig and S-Ig seem different in cells arrested in the stationary 
phase of cell growth. This study has the advantage that some of the difficulties 
in interpreting experiments where metabolic inhibitors are used are avoided. At 
this  phase,  M-Ig  synthesis  is  relatively unaffected  whereas,  as  previously 
shown, the synthesis of S-Ig is terminated (8,  18,  19).  Also, we have demon- 
strated in the current work that in the stationary phase the  C-Ig decreased 
almost 10-fold. A similar discrepancy in the behavior of C-Ig and M-Ig is seen 
in the present studies where metabolic inhibitors were used. 
These  data  in  toto suggest  that  maintenance  of  M-Ig  and  S-Ig  mav  be 
separately  controlled by  the  cell.  Alternative  explanations  for  the  different 
behavior of M-Ig  and  S-Ig can be  considered.  Recently, Bloom et  al.  have 
shown  that  clones  of  cultured  human  lymphocytes  do  not  exhibit  genetic 
exclusion and can synthesize IgG and IgM simultaneously (20). Since we have 
not measured Fc-/~ chains in these experiments, IgM  molecules may have  a 
different  turnover  rate  than  IgG  molecules,  thus  complicating  our  kinetic 
curves of K  chains. This explanation seems unlikely since our Fc-'y does not 
cross-react with Fc-#,  4 and a similar complexity in kinetics is seen when either 
K  chains or Fc-~,  are studied after treatment with inhibitors. The possibility 
that we have two populations of cells is also unlikely since these studies were 
carried out with a clone of cells. 
Since the amount of C-Ig is approximately 40-fold that of M-Ig, and as yet 
there are no markers to distinguish between S-Ig and M-Ig, the catabolic fate 
of M-Ig or the per cent of contribution of the  C-Ig to M-Ig  are difficult to 
establish. One would like to isolate these molecules and do pulse-chase experi- 
ments, but it is not yet possible. However, from the studies in stationary phase 
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ceils where synthesis of M-Ig is relatively unaffected, whereas  the  C-Ig de- 
creases to almost 10%, one can speculate that at least 90% of the Ig in cells 
during logarithmic growth is S-Ig and is not necessary for saturation of M-Ig 
sites. This might be expected since in vivo the bulk of lymphocytes are in the 
Go phase and synthesize relatively little protein but should presumably main- 
tain antigen receptors. 
It is impossible to determine exactly what  relationship may exist between 
the stage of differentiation of the diploid lymphocytes in continuous culture 
and lymphoid cells  after induction of  an immune response in vivo. Morpho- 
logically,  the  cultured  diploid  lymphocytes  are  relatively  undifferentiated 
having little endoplasmic reticulum and few lysosomes.  5 In this respect  they 
resemble the Go lymphocyte. The "stippled" distribution of Ig on the surface 
of our cultured lymphocytes as  studied  by immunofluorescence  is similar  to 
that  seen  in  some  human  peripheral  blood mononuclear leukocytes  stained 
suspension. 6 As continuous cultures capable of responding to specific antigens 
become available it ,nay be possible to drive the cultured cells to differentiate, 
and we can then answer with certainty some of these unresolved problems. 
SUMMARY 
The half disappearance time for detectable plasma membrane-associated and 
cytoplasmic immunoglobulin  after treatment of continuously growing diploid 
lymphocytes with inhibitors of protein and RNA synthesis was studied. Also, 
the amount of plasma membrane-associated and cytoplasmic immunoglobulin 
of synchronized cells in the GI phase of the cell cycle has been studied. Plasma 
membrane-associated  immunoglobulin  has  a  half  disappearance  time  of  45 
rain after inhibition of protein synthesis. By contrast, after treatment of cells 
with  actinomycin D  for 24 hr,  plasma membrane-associated immunoglobulin 
remains relatively unchanged whereas cytoplasmic immunoglobulin decreased 
by ahnost 90 %. In the G1 phase of the cell cycle, plasma membrane-associated 
immunoglobulin and  cytoplasmic immunoglobulin were  70 and  10%,  respec- 
tively, of that in logarithmically growing cells,  and the half disappearance of 
M-Ig after treatment of cells with puromycin was again 45 min. In toto,  these 
results  suggest  that  perhaps  secreted  and  plasma  membrane-associated  im- 
munoglobulin may be separately controlled by the  cells. 
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